Sopharma AD (SPH.WA)
PLN 12.8
(6.22%)
PLN 12.8
(6.22%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.88 Billion BGN | 12.71% |
| 2022 | 1.66 Billion BGN | 3.72% |
| 2021 | 1.6 Billion BGN | 11.43% |
| 2020 | 1.43 Billion BGN | 12.27% |
| 2019 | 1.28 Billion BGN | 8.69% |
| 2018 | 1.17 Billion BGN | 15.93% |
| 2017 | 1.01 Billion BGN | 15.96% |
| 2016 | 877.08 Million BGN | 0.24% |
| 2015 | 874.98 Million BGN | 4.1% |
| 2014 | 840.51 Million BGN | 10.2% |
| 2013 | 762.68 Million BGN | 10.76% |
| 2012 | 688.57 Million BGN | 6.8% |
| 2011 | 644.73 Million BGN | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 509.47 Million BGN | 2.01% |
| 2024 Q2 | 489.37 Million BGN | -3.0% |
| 2023 Q4 | 499.44 Million BGN | 9.03% |
| 2023 FY | 1.87 Billion BGN | 12.71% |
| 2023 Q3 | 458.09 Million BGN | 1.87% |
| 2023 Q1 | 467.2 Million BGN | 5.18% |
| 2023 Q2 | 449.68 Million BGN | -3.75% |
| 2022 Q2 | 405.34 Million BGN | 1.96% |
| 2022 Q3 | 415.88 Million BGN | 2.6% |
| 2022 Q4 | 444.19 Million BGN | 6.81% |
| 2022 Q1 | 397.57 Million BGN | -6.23% |
| 2022 FY | 1.66 Billion BGN | 3.72% |
| 2021 Q3 | 420.28 Million BGN | 10.55% |
| 2021 Q4 | 423.98 Million BGN | 0.88% |
| 2021 FY | 1.6 Billion BGN | 11.43% |
| 2021 Q1 | 378.85 Million BGN | -9.88% |
| 2021 Q2 | 380.18 Million BGN | 0.35% |
| 2020 Q2 | 314.67 Million BGN | -14.38% |
| 2020 FY | 1.43 Billion BGN | 12.27% |
| 2020 Q4 | 420.38 Million BGN | 23.84% |
| 2020 Q3 | 339.44 Million BGN | 7.87% |
| 2020 Q1 | 367.52 Million BGN | 3.0% |
| 2019 Q2 | 298.56 Million BGN | -4.73% |
| 2019 Q4 | 356.81 Million BGN | 14.06% |
| 2019 FY | 1.28 Billion BGN | 8.69% |
| 2019 Q1 | 313.37 Million BGN | -1.54% |
| 2019 Q3 | 312.83 Million BGN | 4.78% |
| 2018 Q2 | 276.89 Million BGN | -5.45% |
| 2018 FY | 1.17 Billion BGN | 15.93% |
| 2018 Q1 | 292.86 Million BGN | -1.52% |
| 2018 Q3 | 291.1 Million BGN | 5.13% |
| 2018 Q4 | 318.28 Million BGN | 9.34% |
| 2017 Q1 | 239.72 Million BGN | 0.43% |
| 2017 Q3 | 249.41 Million BGN | 8.17% |
| 2017 Q4 | 297.39 Million BGN | 19.24% |
| 2017 FY | 1.01 Billion BGN | 15.96% |
| 2017 Q2 | 230.57 Million BGN | -3.82% |
| 2016 Q2 | 207.92 Million BGN | -3.66% |
| 2016 FY | 877.08 Million BGN | 0.24% |
| 2016 Q1 | 215.81 Million BGN | -5.09% |
| 2016 Q4 | 238.69 Million BGN | 11.2% |
| 2016 Q3 | 214.65 Million BGN | 3.24% |
| 2015 FY | 874.98 Million BGN | 4.1% |
| 2015 Q4 | 227.38 Million BGN | 8.9% |
| 2015 Q3 | 208.79 Million BGN | -3.87% |
| 2015 Q2 | 217.19 Million BGN | -1.99% |
| 2015 Q1 | 221.61 Million BGN | -0.53% |
| 2014 Q4 | 222.79 Million BGN | 9.81% |
| 2014 FY | 840.51 Million BGN | 10.2% |
| 2014 Q1 | 214.29 Million BGN | 2.58% |
| 2014 Q2 | 200.53 Million BGN | -6.42% |
| 2014 Q3 | 202.89 Million BGN | 1.18% |
| 2013 Q3 | 183.22 Million BGN | 0.15% |
| 2013 Q4 | 208.89 Million BGN | 14.01% |
| 2013 FY | 762.68 Million BGN | 10.76% |
| 2013 Q1 | 187.6 Million BGN | 2.38% |
| 2013 Q2 | 182.95 Million BGN | -2.48% |
| 2012 Q1 | 173.16 Million BGN | 0.0% |
| 2012 FY | 688.57 Million BGN | 6.8% |
| 2012 Q3 | 159.78 Million BGN | -7.31% |
| 2012 Q4 | 183.24 Million BGN | 14.68% |
| 2012 Q2 | 172.38 Million BGN | -0.45% |
| 2011 FY | 644.73 Million BGN | 0.0% |
| Name | Revenue | Revenue Difference |
|---|